Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Advanced Drug Delivery Improves Gout Management
October 2025
Advanced drug delivery systems may improve outcomes in gout and hyperuricemia by enhancing targeting and tolerability.
Read more
29 Sep 2025
Rheumatic Disease Tied to Higher Surgical Complications
Patients with autoimmune rheumatic diseases face significantly greater risks of complications after undergoing endovascular interventions for lower extremity arterial disease, according to a large U.S. inpatient analysis.
26 Sep 2025
Non-Drug Strategies Ease Pain and Fatigue in Scleroderma
Pain and fatigue are among the most disabling symptoms in systemic sclerosis, and new evidence highlights the promise of non-drug strategies to ease their impact on daily life.
24 Sep 2025
The Future of Predicting Kidney Survival in Vasculitis
Predicting long-term kidney outcomes in patients with ANCA-associated vasculitis (AAV) may be improved by integrating additional clinical markers into existing risk models, according to new research.
22 Sep 2025
Canakinumab Outperforms Anakinra in VEXAS Syndrome
Canakinumab demonstrated significantly greater efficacy and durability than anakinra in the treatment of patients with VEXAS syndrome, according to findings from an international multicenter study.
19 Sep 2025
Psoriasis Burden in Youth Rising Globally
The global burden of psoriasis among adolescents and young adults has increased steadily over the past three decades, with projections indicating further acceleration through 2035.
17 Sep 2025
Surgeons Confront Complex Realities in Knee Pain Care
Surgeons treating patients with unexplained pain after knee arthroplasty face profound clinical and emotional challenges, according to a new qualitative study that highlights the complexity of decision-making in this setting.
15 Sep 2025
Cutaneous Vasculitis Signals Poor Outcomes in Sjögren Disease
Cutaneous vasculitis in primary Sjögren disease is linked to significantly worse outcomes, particularly when cryoglobulinemic vasculitis is present, according to findings from a large multicenter cohort study.
12 Sep 2025
Demand for Rheumatology Advice Lines Outpaces Resources
A new survey highlights that patients with rheumatoid arthritis want faster and more personal access to rheumatology telephone advice lines, underscoring the growing strain on these services.
10 Sep 2025
Bone Density After Hip Surgery Mostly Unchanged
Bone mineral density (BMD) assessment using radiofrequency echographic multispectrometry (REMS) shows that age, sex, and BMI remain the strongest determinants of bone health, even in the context of total hip replacement surgery.
8 Sep 2025
Treatment Patterns in Mantle Cell Lymphoma: Insights from Japan
A new real-world study has mapped the treatment landscape for mantle cell lymphoma (MCL) in Japan, highlighting common patient characteristics, therapeutic strategies, and ongoing gaps in efficacy and quality of life outcomes.
5 Sep 2025
Effectiveness of IL-6 Therapy in the Elderly with Rheumatoid Arthritis
Targeting IL-6 signaling shows reassuring safety and effectiveness in older patients with rheumatoid arthritis (RA), according to recent postmarketing and registry data.
3 Sep 2025
Salivary Ultrasound Adds Value in Sjögren’s Diagnosis
Salivary gland ultrasound (SGUS) demonstrated meaningful diagnostic value for patients with highly suspected Sjögren’s Disease (SjD), particularly when combined with established serological or biopsy measures, according to findings from a prospective monocentric study.
29 Aug 2025
ChatGPT Outperforms Google in SLE Biologic Therapy Guidance
ChatGPT demonstrates higher accuracy and completeness than Google Web Search when providing information about biologic therapy for systemic lupus erythematosus (SLE), according to a new comparative study.
27 Aug 2025
ILD Progression in Rheumatoid Arthritis Linked to Mortality
Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is increasingly recognized as a major factor influencing long-term outcomes in affected patients, with new data showing that disease progression and specific lung patterns significantly impact mortality.
25 Aug 2025
Hidden Rheumatic Causes Found in Young Ischemic Stroke
New findings highlight that underlying rheumatic diseases may play a significant role in ischemic stroke among younger adults, emphasizing the importance of early diagnosis and referral.
22 Aug 2025
Stiffness and Swelling Key to Psoriatic Arthritis Diagnosis
Stiffness and swelling were identified as the most reliable clinical indicators distinguishing psoriatic arthritis from non-inflammatory musculoskeletal conditions in patients with psoriasis, according to a retrospective review from a combined rheumatology-dermatology clinic.
20 Aug 2025
Can Power Doppler Forecast Remission in Rheumatoid Arthritis?
Power Doppler ultrasound may provide important signals in predicting treatment response for patients with rheumatoid arthritis (RA), though its ability to forecast remission remains uncertain, according to a new systematic review.
18 Aug 2025
Real-World Data Show IL-1 Therapy Replacing Corticosteroids in Pericarditis
IL-1 pathway inhibition is increasingly replacing corticosteroids as the preferred second-line treatment for recurrent pericarditis, according to real-world registry data from the RESONANCE study.
15 Aug 2025
Ultrasound Pinpoints Key Psoriatic Arthritis Phenotypes
Ultrasound imaging may offer a more precise way to distinguish between inflammatory and non-inflammatory phenotypes in patients with difficult-to-treat psoriatic arthritis (D2T-PsA), according to new multicentre cross-sectional study findings.
13 Aug 2025
New AI Models Advance Knee Osteoarthritis Prediction
Recent advancements in machine learning (ML) are offering new opportunities to predict the onset and progression of knee osteoarthritis with greater accuracy, supporting earlier intervention and more personalized care.
11 Aug 2025
IL-1 Inhibitors Effective for Refractory SURF Cases
New research has identified clinical features that may predict resistance to colchicine in patients with the syndrome of undifferentiated recurrent fever (SURF), offering potential guidance for more targeted treatment approaches.
8 Aug 2025
Rapid Rise in AI Rheumatology Led by Few
A new bibliometric study highlights the rapid rise in artificial intelligence (AI) research within rheumatology, revealing both the field’s growing significance and the limited group of authors driving this trend.
6 Aug 2025
Cardio-Rheumatology Model Advances Systemic Sclerosis Care
A new interdisciplinary cardio-rheumatology model is paving the way for earlier detection and personalized treatment of cardiac complications in patients with systemic sclerosis, according to a recent review.
1 Aug 2025
Fatal Complication of Retroperitoneal Fibrosis: Key Prognostic Indicators
Retroperitoneal fibrosis (RPF) complicated by fibrosing mediastinitis (FM) is an uncommon but life-threatening condition that warrants early detection and intervention.
30 Jul 2025
CEUS Outperforms Doppler Ultrasound in RA Synovitis Detection
A recent systematic review and meta-analysis have highlighted the enhanced diagnostic ability of contrast-enhanced ultrasound (CEUS) over traditional Doppler ultrasound (DUS) for identifying active synovitis in patients with rheumatoid arthritis (RA).
28 Jul 2025
In Utero Smoking Exposure, A Type 1 Diabetes Risk Paradox
Maternal smoking during pregnancy, as well as DNA methylation (DNAm) smoking scores, may be associated with a reduced risk of islet autoimmunity (IA) and type 1 diabetes (T1D) in children at high risk, according to the results of a new study.
25 Jul 2025
Increased Demyelination Risk in Biologic Therapy for Rheumatic Diseases
A concerning increase in the incidence of central nervous system (CNS) demyelination among patients undergoing biologic treatments for rheumatologic diseases has been revealed by a new study.
23 Jul 2025
Low INR Levels Raise Risk of Recurrent Arterial Thrombosis in APS
Maintaining an INR between 2.5 and 3.5 may significantly reduce the risk of recurrent thrombotic events in patients with primary antiphospholipid syndrome (APS), particularly arterial events, according to a new retrospective study.
19 Jul 2025
Dual Vaccine Shows Strong Immune Response in Adults Over 50
A new multicomponent vaccine targeting both seasonal influenza and SARS-CoV-2 has demonstrated noninferior immunogenicity and acceptable safety in adults aged 50 years and older, according to results from a Phase III randomized trial.
17 Jul 2025
How Menopause Alters Systemic Sclerosis Outcomes
Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.
16 Jul 2025
Global Psoriatic Arthritis Guidelines Reveal Gaps
A new comparative analysis of international guidelines for psoriatic arthritis (PsA) management reveals key divergences in treatment strategies across leading rheumatology societies, underscoring ongoing challenges in global consensus despite shared therapeutic goals.
14 Jul 2025
Interruptions Undermine Lupus Decision Aid Impact
In a new multicenter study, researchers found that the effectiveness of a computerized patient decision aid (PtDA) for systemic lupus erythematosus (SLE) hinges not on where or how it is used but on whether patients view it fully and without interruptions.
11 Jul 2025
Understanding Muscle Dysfunction in Brittle Bone Disease
Muscle impairments are a significant yet understudied burden in patients with osteogenesis imperfecta (OI), with consequences that extend far beyond bone fragility.
9 Jul 2025
Routine Biopsy May Be Key to Catching Lupus Nephritis Early
Lupus nephritis recurrence after kidney transplant may occur silently and more frequently than previously recognized, according to a new multisite retrospective study using both surveillance and indication biopsies.
7 Jul 2025
Rheumatoid Arthritis Therapy Hinges on Infection Check
Screening for latent tuberculosis (TB), hepatitis C virus (HCV), and occult hepatitis B virus (HBV) is critical before initiating biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in patients with rheumatoid arthritis (RA), according to a recent clinical audit conducted in Pakistan.
4 Jul 2025
Mixed Rhinitis May Be Overlooked in Youth
A new study suggests that mixed rhinitis (MR) may be a significantly underrecognized condition in children and adolescents previously diagnosed with allergic rhinitis (AR), with nearly half of patients potentially misclassified.
2 Jul 2025
Stem Cell Strategies Show Promise in Systemic Sclerosis
Stem cell–based therapies may offer a transformative approach for systemic sclerosis, according to a new review that evaluates both current limitations and emerging solutions in regenerative treatment.
30 Jun 2025
Uncovering Pediatric Behçet’s Disease Clusters
New research provides critical insights into the phenotypic clusters of pediatric Behçet’s disease, highlighting the complexity and variability of clinical presentations in children with this rare inflammatory condition.
27 Jun 2025
Men Face Greater Organ Damage in Lupus
SEX significantly influences the onset, severity, and progression of systemic lupus erythematosus (SLE), according to a new scoping review that synthesizes data from nearly a decade of clinical research.
26 Jun 2025
Study Flags Autoimmune Concerns with GLP-1 Use
Patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S. cohort.
25 Jun 2025
Common Osteoarthritis Genes Not Linked to Progression
Genetic risk scores for knee osteoarthritis do not predict disease progression, new cohort study reveals.
20 Jun 2025
New Insight: Balance Dysfunction in Sjogren’s Syndrome
Vestibular dysfunction and impaired balance may be more common in patients with primary Sjogren’s syndrome than previously understood, according to new research exploring the condition’s neurological impact.
18 Jun 2025
Methotrexate Intolerance Not Tied to Administration Route
In a new cross-sectional study, methotrexate intolerance in patients with rheumatoid arthritis (RA) was not significantly associated with dosing frequency or route of administration, according to new findings.
17 Jun 2025
The Rise of Onco-Rheumatology: A New Era Begins
As cancer therapies evolve and autoimmune diseases become more prevalent, the intersection of oncology and rheumatology, onco-rheumatology, is emerging as a critical field demanding transdisciplinary care.
13 Jun 2025
Digital Biomarkers Power New Psoriatic Arthritis Tools
European researchers are pioneering a shift in psoriatic arthritis (PsA) care through the integration of digital tools, explainable AI, and personalized health solutions, paving the way for earlier detection and more tailored treatment strategies in complex rheumatologic conditions.
11 Jun 2025
Autoimmune Thyroid Disorders Significantly More Common in SLE
Autoimmune thyroid disorders are significantly more common in patients with systemic lupus erythematosus (SLE), but they do not appear to worsen disease outcomes, according to a recent case-control study.
6 Jun 2025
Chronic Back Pain: Which Therapies Last?
Cognitive behavioral therapy (CBT) and mindfulness may offer sustained reductions in pain and disability for adults with non-specific chronic low back pain, according to a new systematic review and meta-analysis of 75 randomized controlled trials encompassing over 15,000 participants.
4 Jun 2025
Rheumatoid Arthritis Raises Tuberculosis Risk Despite Screening
In a major new study of over 350,000 individuals, researchers have uncovered compelling evidence that patients with rheumatoid arthritis face a significantly higher risk of developing active pulmonary tuberculosis, even in modern healthcare settings where tuberculosis screening precedes biologic treatment.
2 Jun 2025
Earlier Geriatric Assessment Improves Hip Fracture Outcomes
Early geriatric assessments in older adults with hip fractures are strongly associated with improved recovery, reduced hospital stays, and lower complication rates, according to a new systematic review.
31 May 2025
Which Therapies Help Pediatric Rheumatic Fatigue?
A new systematic review has found limited and inconsistent evidence for the effectiveness of current fatigue-reducing interventions in children and adolescents with pediatric rheumatic diseases (PRDs), underscoring the urgent need for more rigorous and targeted clinical research.
28 May 2025
Are Spondyloarthritis Diagnostic Criteria Failing Latin America?
Spondyloarthritis (SpA) classification criteria show variable diagnostic performance in Latin American populations, according to a newly published systematic review and meta-analysis.
23 May 2025
Osteoarthritis Surgery Reviewed: Risks, Results, and Recommendations
Surgical intervention for severe osteoarthritis continues to be a critical decision point in orthopedics.
21 May 2025
1 in 10 Liver Transplant Patients Still Break Bones Despite Protocol
Liver transplant patients face a substantial risk of bone fractures despite following specialized care protocols, according to new findings.
19 May 2025
Can Psoriatic Arthritis Go Drug-Free? Surprising New Data
In a breakthrough study that could reshape long-term treatment strategies for psoriatic arthritis (PsA), researchers have found that a small but significant proportion of patients can achieve and maintain remission without the continued use of disease-modifying antirheumatic drugs (DMARDs).
16 May 2025
Optimal Timing of Rehabilitation in Hand Fracture Recovery
In a landmark systematic review and meta-analysis, researchers have shed new light on the optimal timing for mobilization following open reduction and internal fixation (ORIF) of hand fractures.
14 May 2025
Why Patients with Inflammatory Arthritis Struggle to Stay Employed
Healthcare professionals working with people with inflammatory arthritis (IA) report that emotional, economic and social barriers significantly impact patients’ ability to stay employed.
12 May 2025
Ultrasound Strain Imaging Reveals Hidden Cardiovascular Risk in RA
Rheumatoid arthritis (RA) has long been linked to increased cardiovascular disease risk, and new findings using speckle tracking strain ultrasonography reveal the extent of subclinical vascular damage in this patient population.
9 May 2025
Could Timing Between Births Affect Osteoarthritis Risk Later in Life?
In a new analysis of U.S. postmenopausal women, researchers have uncovered a striking U-shaped relationship between reproductive timing and osteoarthritis (OA) risk, suggesting that the spacing between childbirths and maternal age at delivery could influence long-term joint health.
7 May 2025
Improving Bedside Nursing With ISBAR Communication
Improving communication between nurses is critical to patient safety and care quality, particularly in complex specialties like rheumatology and immunology.
5 May 2025
How Rheumatologists Choose Specialists to Refer To
Understanding referral patterns in rheumatic disease management is crucial to improving interdisciplinary care and patient outcomes.
2 May 2025
Are JAK Inhibitors Raising VTE Risk in Rheumatoid Arthritis?
In patients with rheumatoid arthritis (RA), understanding the risk of venous thromboembolism (VTE) is increasingly important as treatment strategies evolve.
30 Apr 2025
Growth and Hormonal Disruptions in Juvenile Arthritis
Juvenile idiopathic arthritis (JIA), the most common chronic rheumatic disease in children, may carry underrecognized risks for endocrine dysfunction, according to a new study that highlights significant growth and hormonal disturbances in this vulnerable population.
28 Apr 2025
Study Reveals Sleep Loss May Spark Autoimmune Conditions
Chronic insomnia, already known for its toll on mental and physical health, has now been linked to an increased risk of developing specific autoimmune diseases, according to a recent large-scale cohort study conducted in the United States.
25 Apr 2025
Targeted RA Therapies: Lessons from Aging Japan
In Japan, home to the world’s most rapidly aging society, managing rheumatoid arthritis (RA) in elderly patients has posed unique challenges for healthcare providers.
23 Apr 2025
Multimorbidity in Systemic Sclerosis: Hidden Driver of Poor Outcomes
Multimorbidity, the presence of multiple co-existing health conditions, has emerged as a critical factor influencing survival and physical function in patients with systemic sclerosis (SSc), according to a large cohort study of 2,000 participants.
21 Apr 2025
Why Patients With Rheumatoid Arthritis Are Losing Sleep
New research reveals that adults with rheumatoid arthritis (RA) are significantly more likely to develop sleep disorders, including insomnia, than those without the disease, a finding that raises important questions for rheumatologists and primary care providers.
18 Apr 2025
Why Males Face Higher Risks After Hip Fracture Surgery
New U.S. data analyzing 90-day outcomes after nonelective total hip arthroplasty (THA) for hip fracture reveals that male patients and those with pre-existing comorbidities face significantly higher risks of readmission and in-hospital mortality.
16 Apr 2025
Laser vs Diathermy: OA Treatment Outcomes Comparison Trial
In a randomized trial, researchers evaluated two physical therapy approaches—high-intensity laser therapy (HILT) and short-wave diathermy (SWD), each combined with exercise, for treating patients with Stage 2–3 knee osteoarthritis.
14 Apr 2025
Steroid Dependency Persists in Late-Onset Rheumatoid Arthritis
In older adults with newly diagnosed late-onset rheumatoid arthritis (LORA), long-term glucocorticoid (GC) use remains persistent for a notable subset, according to a new analysis of national Medicare data spanning nearly a decade.
11 Apr 2025
Unexpected Cellular Activity Found in SSc-Linked Calcinosis
In patients with systemic sclerosis (SSc), the presence of calcinosis cutis, abnormal calcium deposits in the skin, may signal a deeper issue tied to osteoclastogenesis, the formation of bone-resorbing cells, according to a new study.
9 Apr 2025
New Criteria Improve Diagnosis of IgG4-Related Arterial Disease
Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.
7 Apr 2025
Skin Thickening Rate Signals Cardiopulmonary Risk
A new prospective cohort study has found that the rate of skin thickening progression in patients with systemic sclerosis (SSc), measured using the modified Rodnan skin score (mRSS), is closely correlated with the early onset of serious cardiopulmonary complications, including interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH).
4 Apr 2025
Exploring the Effects of Nutrition on Juvenile Arthritis: One-Year Study Results
A new study examining the long-term effects of a specific carbohydrate diet (SCD) in children with juvenile idiopathic arthritis (JIA) suggests potential benefits, particularly for individuals seeking to avoid medication escalation.
2 Apr 2025
AI Improves Vasculitis Detection to 97% According to New Findings
AI is making significant strides in the diagnosis and outcome prediction of vasculitides, rare inflammatory disorders that can be challenging to identify due to their diverse clinical presentations.
28 Mar 2025
How Juvenile Arthritis Disrupts Puberty in Children
Children with juvenile idiopathic arthritis (JIA) face more than just joint pain, emerging research reveals that the condition may significantly delay puberty.
26 Mar 2025
Adipose Stem Cells: Transforming Care in Systemic Sclerosis
Adipose-derived stem cells (ADSCs) may offer a groundbreaking new approach to treating systemic sclerosis (SSc), according to a recent study.
24 Mar 2025
Nintedanib May Slow Lung Function Decline in SSc-ILD
A recent analysis of the SENSCIS and SENSCIS-ON trials has demonstrated that nintedanib effectively slows the decline in forced vital capacity (FVC) among patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
21 Mar 2025
Medical Cannabis Linked to Hypermobility-Associated Chronic Pain Relief
A recent study conducted with the UK Medical Cannabis Registry evaluated the impact of cannabis-based medicinal products (CBMPs) on patients suffering from chronic pain due to hypermobility spectrum disorder (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS).
19 Mar 2025
How AI is Changing Kawasaki Disease Diagnosis
AI is emerging as a promising tool in the diagnosis and management of vasculitides, a group of rare inflammatory disorders that pose significant diagnostic challenges.
17 Mar 2025
How Reliable Is the New Scleroderma Skin Questionnaire?
The psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) designed to assess skin disease in patients with systemic sclerosis (SSc), has been evaluated in a new study.
14 Mar 2025
Cancer Outcomes in Rheumatoid Arthritis: Increased Mortality Rates
A recent long-term population study from Western Australia has revealed critical insights into the relationship between rheumatoid arthritis (RA) and cancer outcomes.
12 Mar 2025
Comparing Immunosuppressants: What Works Best in Systemic Sclerosis?
A recent analysis from the RESOLVE-1 trial has highlighted the potential of mycophenolate mofetil (MMF) in treating diffuse cutaneous systemic sclerosis (dcSSc), particularly in early-stage disease.
5 Mar 2025
Reducing Heart Risks in Arthritis: The Role of TNF Inhibitors
Inflammation is increasingly recognized as a pivotal factor in the development of atherosclerosis and its associated thrombotic complications.
26 Feb 2025
RA Drugs Show Promise Despite Kidney Issues
Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.
21 Feb 2025
GERD Symptoms Linked to Worse RA Outcomes
Gastroesophageal (GE) symptoms, such as acid reflux and heartburn, are significantly associated with higher disease activity in patients with rheumatoid arthritis (RA), according to a new study.
19 Feb 2025
What Are Best Next Steps After JAKi Failure?
For patients with rheumatoid arthritis (RA) with an inadequate response to Janus kinase inhibitors (JAKi), new research suggests that cycling to another JAKi may be more effective than switching to a biologic disease-modifying anti-rheumatic drug (bDMARD).
15 Feb 2025
Cardiovascular Imaging Breakthroughs for Rheumatic Disease
A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).
10 Feb 2025
Study Reveals Bone Erosion Patterns in Sjögren's
A recent cross-sectional study conducted at a quaternary hospital in Brazil has provided new insights into joint involvement in Sjögren’s disease (SjD), challenging its traditional classification as a non-erosive condition.
6 Feb 2025
A Game-Changer for Precision Medicine in Rheumatoid Arthritis
The potential of high-content imaging as a game-changer for precision medicine in rheumatoid arthritis (RA) has been highlighted in a new study.
31 Jan 2025
Ketogenic Diet May Exacerbate Osteoarthritis and Pain
A ketogenic diet (KD) may worsen osteoarthritis (OA) severity and increase pain sensitivity according to the results of a new study.
29 Jan 2025
Immune Checkpoint Inhibitors: A Balancing Act
Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.
24 Jan 2025
Lifestyle Care Favored Over Guidelines for Back Pain
A recent randomized clinical trial has demonstrated that incorporating healthy lifestyle care into chronic low back pain management can provide small but meaningful improvements in disability, weight loss, and quality of life.
22 Jan 2025
How Air Quality Impacts Autoimmune Health
A genetic link between air pollution exposure and the risk of developing autoimmune diseases such as rheumatoid arthritis (RA), lupus, and psoriasis, has been identified in a new study.
20 Jan 2025
Dynamic Frailty Trends in Systemic Sclerosis
Frailty, a dynamic and clinically significant condition, is prevalent among patients with systemic sclerosis (SSc), according to a recently published study.
17 Jan 2025
Bridging Psoriatic Arthritis Communication Barriers
The way patients and clinicians prioritize different aspects of psoriatic arthritis (PsA) has been revealed in a new study that shed light on important disparities that could impact care quality and outcomes.
15 Jan 2025
Salivary Biomarkers Aid in Sjögren’s Detection
A diagnostic model has been developed for primary Sjögren’s disease (pSjD), utilizing salivary biomarkers, serum autoantibodies, and Schirmer’s test.
10 Jan 2025
Medication-Free Remission in Juvenile Dermatomyositis
Achieving medication-free remission (MFR) is a critical milestone in the treatment of juvenile dermatomyositis (JDM), a rare inflammatory disease primarily affecting skin and muscles.
8 Jan 2025
Exploring Botulinum Toxin for Raynaud’s Treatment
Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for Raynaud’s phenomenon (RP), particularly when secondary to scleroderma.
6 Jan 2025
Premature Rheumatoid Arthritis Death Surge in Native Americans
Native Americans experience the highest premature mortality rates from rheumatoid arthritis (RA) in the United States, according to a comprehensive study analyzing national data from 1999 to 2020.
1 Jan 2025
TNF Inhibitors Lower Fracture Risk in Axial Spondylarthritis
TNF inhibitors reduce fracture risk in axial spondyloarthritis, offering protection against complications from chronic inflammation.
29 Dec 2024
Study Highlights Cancer Risks and Outcomes for Rheumatoid Arthritis Patients
A new study from Western Australia reveals that while patients with rheumatoid arthritis (RA) have a lower overall cancer incidence compared to the general population, they face higher risks for lung and hematological cancers.
20 Dec 2024
Axial Spondyloarthritis More Severe in Black Americans
A recent study conducted across five centers in Shelby County, Tennessee, reveals concerning disparities in the diagnosis and severity of axial spondyloarthritis (axSpA) in Black Americans.
18 Dec 2024
Estrogen-Progesterone Therapy Linked to Autoimmune Risks
A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.
17 Dec 2024
Predictors of Psoriatic Arthritis in Juvenile Arthritis
Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.
13 Dec 2024
Treg Cells: Helpers or Harmers in Arthritis?
Regulatory T (Treg) cells are vital for immune system balance, preventing autoimmune diseases by suppressing inflammation.
11 Dec 2024
Is Drug-Free Remission Sustainable In Giant Cell Arteritis?
According to a new study, achieving sustained drug-free remission (SDFR) in giant cell arteritis (GCA) is possible for a significant subset of patients, with low relapse rates once remission is reached.
9 Dec 2024
Infertility Without Treatment Increases Systemic Autoimmune Rheumatic Disease Risk
Females who experience infertility but do not use fertility treatment may be at an increased risk for developing systemic autoimmune rheumatic disease (SARD) after childbirth, according to a new population-based cohort study.
6 Dec 2024
Minimally Invasive Treatment Delays Knee Surgery
Genicular artery embolization (GAE), a minimally invasive procedure, offers promising relief for patients with knee osteoarthritis, potentially delaying or eliminating the need for knee replacement surgery, according to new findings presented at the Radiological Society of North America (RSNA) annual meeting.
4 Dec 2024
Knee Pain Treatment with Colchicine Falls Short
Investigation into colchicine’s potential as a treatment for knee osteoarthritis (OA) found no significant improvement in pain or function in a recent study.
2 Dec 2024
Women with PsA Experience Longer Time to Diagnosis than Men
Women with psoriatic arthritis (PsA) experience longer delays in diagnosis, more intense symptoms, and distinct challenges with treatment compared to men, according to findings presented by Lihi Eder at ACR Convergence 2024.
29 Nov 2024
How To Talk To Your Patient About Cannabis
Medical cannabis, a widely debated topic, took center stage at the ACR Convergence 2024, where researchers explored its role in managing chronic pain related to rheumatic diseases.
27 Nov 2024
New Pathway for OA Treatment: ACR24
Sodium channels in cartilage cells may hold the key to treating osteoarthritis (OA), a new study presented at ACR Convergence 2024 unveiled.
24 Nov 2024
The Key Role of Partners in Rheumatoid Arthritis Care
The way couples manage stress together profoundly impacts outcomes for patients with rheumatoid arthritis (RA), according to a new study.
22 Nov 2024
Biologics Breakthrough: Trends in Juvenile Arthritis Over 20 Years
The treatment landscape for juvenile idiopathic arthritis (JIA) has shifted significantly over the past two decades, according to a new study analyzing DMARD (disease-modifying antirheumatic drug) utilization among commercially insured children in the United States from 2001 to 2022.
19 Nov 2024
Inebilizumab Targets IgG4 Disease Flares
Inebilizumab, a CD19+ B-cell depleting therapy, can reduce flares and promote remission in patients with IgG4-related disease (IgG4-RD) according to the results of a new Phase III clinical trial.
19 Nov 2024
CRISPR Study Reveals Novel Rheumatoid Arthritis Targets: ACR24
Novel molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at the ACR Convergence 2024 in Washington, D.C.
19 Nov 2024
Nipocalimab In Phase II Sjögren’s Disease Trial Results: ACR24
Data from the DAHLIAS Phase II was presented at ACR Convergence 2024 in Washington, D.C., as part of an abstract plenary session, sharing efficacy and safety of nipocalimab in treating primary Sjögren’s disease.
18 Nov 2024
Novel Steroid-Sparing SLE Solution: ACR24
Evidence supporting a novel therapeutic target for systemic lupus erythematosus (SLE), the E3 ubiquitin ligase “E3-X”, was presented at ACR Convergence 2024 in Washington, D.C.
18 Nov 2024
PI3K Pathway Identified as Key in SSc Skin Fibrosis: ACR2024
Researchers unveiled a groundbreaking study shedding light on the complex molecular interplay driving fibrosis in diffuse systemic sclerosis (dcSSc) at ACR 2024 in Washington, D.C., USA.
17 Nov 2024
Cellular Impacts In Antisynthetase Syndrome: ACR24
New research into how antisynthetase autoantibodies disrupt critical enzymatic functions in muscle cells was presented as part of a plenary abstract session at ACR Convergence 2024 in Washington, D.C.
17 Nov 2024
RISE-Registry Enrollment Elevates Care Quality: ACR24
Participation in the Rheumatology Informatics System for Effectiveness (RISE), an electronic heath record (EHR)-enabled registry designed by the American College of Rheumatology (ACR), significantly improves clinical care metrics, according to a study presented at ACR Convergence 2024.
16 Nov 2024
Efficacy and Safety of Upadacitinib in SELECT-GCA Phase III Trial Results: ACR24
A Phase III clinical trial presented at ACR Convergence 2024 revealed that upadacitinib (UPA), combined with a 26-week glucocorticoid (GC) improved disease control and reduced steroid exposure compared to a placebo (PBO) regimen in patients with giant cell arteritis (GCA).
16 Nov 2024
Global Recruiting Patterns Linked To Placebo Responses in PsA Clinical Trials: ACR24
Presented at the ACR Convergence 2024, new research highlighted how changing global recruitment patterns influence placebo response rates in clinical trials for psoriatic arthritis (PsA).
9 Nov 2024
Once-Weekly Semaglutide: Relief for Knee Pain?
In a groundbreaking study, once-weekly semaglutide injections were shown to significantly reduce both knee osteoarthritis pain and body weight in adults with obesity, offering promising new relief for patients with limited treatment options.
5 Nov 2024
Stress-Related Trauma: A Catalyst in Autoimmune Disease?
Recent findings have underscored the role of traumatic stress as a potent trigger for autoimmune rheumatic diseases (ARDs), emphasizing a feedback loop that perpetuates these conditions.
23 Oct 2024
Lupus in Pregnancy Linked to Placental Damage
Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.
18 Oct 2024
How Do Extreme Temperatures Affect Raynaud’s Phenomenon?
Hot and cold outdoor temperatures significantly worsen Raynaud’s phenomenon in patients with systemic sclerosis, according to new research.
30 Sep 2024
Advanced Imaging Techniques to Transform Arthritis Diagnosis
Adoption of cutting-edge imaging technologies and innovative use of existing methods may revolutionize the diagnosis and treatment of inflammatory arthritis.
21 Sep 2024
Higher Secukinumab Dose Fails to Improve Outcomes
New study found that increasing secukinumab dosage to 300 mg provides no significant benefit for ankylosing spondylitis patients who did not respond to 150 mg.
13 Sep 2024
Is Radiotherapy Safe for Patients with Systemic Sclerosis?
The effects of radiotherapy on patients with systemic sclerosis (SSc) who develop cancer is a subject of growing concern due to the potential exacerbation of SSc symptoms and the risks of radiotherapy-related toxicity.
9 Sep 2024
Shared Care Decisions Boost Physician–Patient Trust: The TRUMP2-SLE Study
Patient participation in shared decision-making is said to be beneficial when it comes to disease management, yet, few studies have researched this in the management of systemic lupus erythematosus.
27 Aug 2024
Rising Infections in Hospitalised Children with Lupus
A new study brought to light significant risks associated with infections in children and adolescents with childhood-onset systemic lupus erythematosus.
14 Aug 2024
Neighbourhood Deprivation Tied to Severe Lupus Skin Disease
A recent study has identified an association between neighbourhood deprivation and the severity of discoid lupus erythematosus in adult patients.
2 Jan 2024
Rheumatoid Arthritis Linked to Higher Heart Failure Risk
Rheumatoid arthritis nearly doubles the risk of heart failure, driven by inflammation-linked HFpEF, highlighting the need for proactive cardiovascular care.
Loading posts...
« Previous
1
…
18
We’ve noticed you’re accessing
from
North/South America.
View
View